Literature DB >> 10201903

The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells.

S A Kellermann1, S Hudak, E R Oldham, Y J Liu, L M McEvoy.   

Abstract

Dendritic cell migration to secondary lymphoid tissues is critical for Ag presentation to T cells necessary to elicit an immune response. Despite the importance of dendritic cell trafficking in immunity, at present little is understood about the mechanisms that underlie this phenomenon. Using a novel transwell chemotaxis assay system, we demonstrate that the CC chemokine receptor-7 (CCR7) ligands 6Ckine and macrophage inflammatory protein (MIP)-3 beta are selective chemoattractants for MHC class IIhigh B7-2high bone marrow-derived dendritic cells at a potency 1000-fold higher than their known activity on naive T cells. Furthermore, these chemokines stimulate the chemotaxis of freshly isolated lymph node dendritic cells, as well as the egress of skin dendritic cells ex vivo. Because these chemokines are expressed in lymphoid organs and 6Ckine has been localized to high endothelial venules and lymphatic endothelium, we propose that they may play an important role in the homing of dendritic cells to lymphoid tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201903

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

Review 1.  Immune chemokines and their receptors: the key elements in the genesis, homeostasis and function of the immune system.

Authors:  O Yoshie
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Dendritic cells and immune regulation in the liver.

Authors:  A H Lau; A W Thomson
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

3.  MT1-MMP regulates the PI3Kδ·Mi-2/NuRD-dependent control of macrophage immune function.

Authors:  Ryoko Shimizu-Hirota; Wanfen Xiong; B Timothy Baxter; Steven L Kunkel; Ivan Maillard; Xiao-Wei Chen; Farideh Sabeh; Rui Liu; Xiao-Yan Li; Stephen J Weiss
Journal:  Genes Dev       Date:  2012-02-15       Impact factor: 11.361

Review 4.  Impact of aging on dendritic cell functions in humans.

Authors:  Anshu Agrawal; Sudhir Gupta
Journal:  Ageing Res Rev       Date:  2010-07-07       Impact factor: 10.895

5.  Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors.

Authors:  Bernard Piqueras; John Connolly; Heidi Freitas; Anna Karolina Palucka; Jacques Banchereau
Journal:  Blood       Date:  2005-11-29       Impact factor: 22.113

Review 6.  Biology of dendritic cells in aging.

Authors:  Anshu Agrawal; Sudhanshu Agrawal; Jia Tay; Sudhir Gupta
Journal:  J Clin Immunol       Date:  2007-09-09       Impact factor: 8.317

7.  Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.

Authors:  Ulrike Haessler; Marco Pisano; Mingming Wu; Melody A Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

Review 8.  Dendritic cell biology and regulation of dendritic cell trafficking by chemokines.

Authors:  C Caux; S Ait-Yahia; K Chemin; O de Bouteiller; M C Dieu-Nosjean; B Homey; C Massacrier; B Vanbervliet; A Zlotnik; A Vicari
Journal:  Springer Semin Immunopathol       Date:  2000

9.  Immunosuppressive treatment protects against angiotensin II-induced renal damage.

Authors:  Dominik N Muller; Erdenechimeg Shagdarsuren; Joon-Keun Park; Ralf Dechend; Eero Mervaala; Franziska Hampich; Anette Fiebeler; Xinsheng Ju; Piet Finckenberg; Jürgen Theuer; Christiane Viedt; Joerg Kreuzer; Harald Heidecke; Hermann Haller; Martin Zenke; Friedrich C Luft
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

10.  Characterization of immune functions in TRAF4-deficient mice.

Authors:  Julien Cherfils-Vicini; Benoit Vingert; Audrey Varin; Eric Tartour; Wolf-Herman Fridman; Catherine Sautès-Fridman; Catherine H Régnier; Isabelle Cremer
Journal:  Immunology       Date:  2008-02-18       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.